Clinical outcome in Down syndrome patients with congenital heart disease

Efrén Martínez-Quintana1, Fayna Rodríguez-González, José María Medina-Gil

  • 1Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain. efrenmartinezquintana@yahoo.es

Cirugia Y Cirujanos
|July 21, 2010
PubMed

Insights

Long-term complications in Down syndrome patients with congenital heart disease are not well understood. This study found left atrioventricular valve insufficiency and left ventricle outflow tract obstruction were common issues requiring reoperation.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatric Medicine

Background:

  • Long-term outcomes for patients with Down syndrome and congenital heart disease (CHD) are not well-documented.
  • Atrioventricular septal defect (AVSD) is a common CHD in Down syndrome patients.

Purpose of the Study:

  • To investigate the long-term complications in adult patients with Down syndrome and congenital heart disease.
  • To compare the incidence of left atrioventricular valve insufficiency in patients with and without Down syndrome who have atrioventricular septal defects.

Main Methods:

  • Retrospective study of 317 patients with congenital heart disease followed from 2004-2008.
  • Analysis of 19 Down syndrome patients with CHD, focusing on diagnosis, surgical history, and long-term complications.
  • Comparison of left atrioventricular valve insufficiency rates between AVSD patients with and without Down syndrome.

Main Results:

  • Down syndrome patients constituted 6% of the CHD cohort, with AVSD being the most frequent diagnosis (63%).
  • Reoperations were required in 53% of operated patients due to left ventricle outflow tract obstruction or left atrioventricular valve insufficiency.
  • Eisenmenger syndrome, bacterial endocarditis, and mortality were observed; bosentan showed potential benefit in functional class improvement for Eisenmenger syndrome.

Conclusions:

  • Left atrioventricular valve insufficiency and left ventricle outflow tract obstruction are significant long-term complications in patients with atrioventricular septal defect, often necessitating surgical reintervention.
  • No significant difference in left atrioventricular valve insufficiency was found between AVSD patients with and without Down syndrome.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...